Headache prevalence and clinical features in patients with idiopathic intracranial hypertension (IIH)

被引:30
|
作者
D'Amico, D. [1 ]
Curone, M. [1 ]
Ciasca, P. [2 ]
Cammarata, G. [2 ]
Melzi, L. [2 ]
Bussone, G. [1 ]
Marzoli, S. Bianchi [2 ]
机构
[1] C Besta Neurol Inst & Fdn, Dept Clin Neurosci, Headache Unit, I-20133 Milan, Italy
[2] Italian Auxol Inst Fdn, Neuroophthalmol Serv, Milan, Italy
关键词
Idiopathic intracranial hypertension (IIH); Headache; Intracranial pressure (ICP); Body mass index (BMI);
D O I
10.1007/s10072-013-1388-7
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Headache is a key symptom of idiopathic intracranial hypertension (IIH). Operational diagnostic criteria for "Headache attributed to IIH" are included in the international classification of headache disorders, the ICHD-2. The association of IIH with obesity was established by several reports. We investigate the prevalence of headache and its main clinical features in a clinical sample of IIH patients. The possible correlations between the presence of headache and body mass index (BMI) and intracranial pressure (ICP) levels were studied in a consecutive clinical series of patients, in whom diagnosis of IIH was confirmed by exclusion of secondary forms and by the evidence of increased ICP. Differences for age, BMI, and ICP between patients with and without headache and between males and females were assessed with Mann-Whitney U test. Spearman's correlation analysis was used to assess relationships between age, BMI, and ICP. P value < 0.05 was used to set statistical significance. 40 patients entered the study (9 males, 31 females; mean age 39, 8 years, SD 13.2). Headache was reported by 75 % patients. Those characteristics which are included in the present international diagnostic criteria for "Headache attributed to IIH" were reported by a remarkable proportion of the studied patients, but not by all. On the other hand, some headache features usually attributed to migraine forms, and which are not among the required criteria were present in some patients: pulsating quality and unilateral distribution of pain in around 20 %, and migrainous associated symptoms in more than 40 % of the sample. According to statistical analyses, no differences were found for age, BMI, and ICP between patients with and without headache. Our results confirmed the strong association between headache and IIH. Although no significant correlations between some of the key features of IIH were found in this study, we suggest that further studies on larger series-possibly with a longitudinal evaluation-are needed, to help clinicians in categorizing different subgroups among IIH patients as well as in identifying the main factors influencing the prognosis of this disorder.
引用
收藏
页码:S147 / S149
页数:3
相关论文
共 50 条
  • [31] Medication overuse headache - An under-diagnosed problem in shunted idiopathic intracranial hypertension patients
    deSouza, Ruth-Mary
    Toma, Ahmed
    Watkins, Laurence
    BRITISH JOURNAL OF NEUROSURGERY, 2015, 29 (01) : 30 - 34
  • [32] An Unusual Case of Headache in a Child: Idiopathic Intracranial Hypertension with Diagnostic Challenge
    Alqahtani, Youssef Ali M.
    Aljabri, Mohammed Fahad
    Oshi, Mohammed Ahmed Mohammed
    Kamal, Naglaa M.
    Elhaj, Waleed
    Abosabie, Sara A.
    Abosabie, Salma A. S.
    CLINICAL MEDICINE INSIGHTS-CASE REPORTS, 2023, 16
  • [33] An Unusual Case of Headache in a Child: Idiopathic Intracranial Hypertension with Diagnostic Challenge
    Alqahtani, Youssef Ali M.
    Aljabri, Mohammed Fahad
    Oshi, Mohammed Ahmed Mohammed
    Kamal, Naglaa M.
    Elhaj, Waleed
    Abosabie, Sara A.
    Abosabie, Salma A. S.
    CLINICAL MEDICINE INSIGHTS-CASE REPORTS, 2023, 16
  • [34] Idiopathic intracranial hypertension without headache: A case report and literature review
    Eren, Yasemin
    Kabatas, Naciye
    Gungor Yavasoglu, Nese
    Comoglu, Selim Selcuk
    AGRI-THE JOURNAL OF THE TURKISH SOCIETY OF ALGOLOGY, 2018, 30 (03): : 142 - 145
  • [35] Experimental drugs for the treatment of idiopathic intracranial hypertension (IIH): shedding light on phase I and II trials
    Khatkar, Pavan
    Hubbard, Jess
    Hill, Lisa
    Sinclair, Alexandra
    Mollan, Susan
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2023, 32 (12) : 1123 - 1131
  • [36] Incidence and predictors of dural venous sinus pressure gradient in idiopathic intracranial hypertension and non-idiopathic intracranial hypertension headache patients: results from 164 cerebral venograms
    Levitt, Michael R.
    Hlubek, Randall J.
    Moon, Karam
    Kalani, M. Yashar S.
    Nakaji, Peter
    Smith, Kris A.
    Little, Andrew S.
    Knievel, Kerry
    Chan, Jane W.
    McDougall, Cameron G.
    Albuquerque, Felipe C.
    JOURNAL OF NEUROSURGERY, 2017, 126 (02) : 347 - 353
  • [37] Calcitonin gene related peptide monoclonal antibody treats headache in patients with active idiopathic intracranial hypertension
    Yiangou, Andreas
    Mitchell, James L.
    Vijay, Vivek
    Grech, Olivia
    Bilton, Edward
    Lavery, Gareth G.
    Fisher, Claire
    Edwards, Julie
    Mollan, Susan P.
    Sinclair, Alexandra J.
    JOURNAL OF HEADACHE AND PAIN, 2020, 21 (01)
  • [38] Calcitonin gene related peptide monoclonal antibody treats headache in patients with active idiopathic intracranial hypertension
    Andreas Yiangou
    James L. Mitchell
    Vivek Vijay
    Olivia Grech
    Edward Bilton
    Gareth G. Lavery
    Claire Fisher
    Julie Edwards
    Susan P. Mollan
    Alexandra J. Sinclair
    The Journal of Headache and Pain, 2020, 21
  • [39] The patients’ perspective on the burden of idiopathic intracranial hypertension
    Max Witry
    Christine Kindler
    Johannes Weller
    Andreas Linder
    Ullrich Wüllner
    The Journal of Headache and Pain, 2021, 22
  • [40] Clinical Features of Pediatric Idiopathic Intracranial Hypertension and Applicability of New ICHD-3 Criteria
    Moavero, Romina
    Sforza, Giorgia
    Papetti, Laura
    Battan, Barbara
    Tarantino, Samuela
    Vigevano, Federico
    Valeriani, Massimiliano
    FRONTIERS IN NEUROLOGY, 2018, 9